Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to investigate the bioequivalence of 80 mg telmisartan/12.5 mg hydrochlorothiazide
(HCTZ) fixed dose combination compared with its monocomponents